Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE1927.10-35.95 (-1.83 %)
PREV CLOSE ( ) 1963.05
OPEN PRICE ( ) 1963.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2234
TODAY'S LOW / HIGH ( )1900.00 1963.85
52 WK LOW / HIGH ( )1551.05 2636
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990
Management Info
C C Paarthipan - Chairman Sridhar Ganesan - Managing Director
Registered Office

Address 3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone 044-24968000 / 8012772888 / 71148000

Email info@caplinpoint.net

Website www.caplinpoint.net

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
 Listing : BSE, NSE
NEWS
08Dec Caplin Point Laboratories’ arm gets
Caplin Point Laboratories’ Subsidiary -- Caplin Steriles has received..
05Nov Caplin Point Laboratories informs abou
Further to intimation dated 29th October, 2025 Caplin Point Laboratories..
23Oct Caplin Point’s arm gets USFDA’s ap
Caplin Point Laboratories’ Subsidiary -- Caplin Steriles has received..
04Oct Caplin Point Laboratories informs abou
Caplin Point Laboratories has submitted a Certificate under Regulation 7..
03Sep Caplin Point’s arm gets USFDA’s fi
Caplin Point Laboratories’ subsidiary -- Caplin Steriles has been gran..
MORE
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit1025.93394.9
Gross Profit 1290 4416.7
Operating Profit 1350.74665.6
Net Sales 1751.87524.1
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Ajanta Pharma (BSE)
up  2660.70 (0.83%)
M.Cap ( in Cr)33241.62
Venus Remedies (BSE)
up  763.50 (2.46%)
M.Cap ( in Cr)1020.57
Everest Organics (BSE)
up  454.90 (4.06%)
M.Cap ( in Cr)441.73
RPG Life Sciences (BSE)
up  2240.65 (0.53%)
M.Cap ( in Cr)3705.81
Sanjivani Paranteral (BSE)
up  213.65 (3.99%)
M.Cap ( in Cr)262.45
MORE
Shareholding Pattern
PROMOTERS 70.57%
NON-INSTITUTION 20.82%
MUTUAL FUNDS/UTI 1.79%
FI/BANKS/INSURANCE 0.23%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
For Nomination, Please Click Here
To Close Account, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.